We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CBK:CRYPTOCAPMarket Cap CBK, $ Analysis

Data as of 2026-05-25 - not real-time

$28.69

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Commercial Bancgroup (CBK) is trading at $28.69, just above its 20‑day SMA of $28.68 and comfortably above the 50‑day SMA of $27.61, indicating a short‑term bullish bias. Volume is increasing and the stock holds a solid support level at $27.25, while resistance sits near $29.75, offering modest upside. The RSI of 54 suggests the price is not overbought, and although the MACD shows a bearish histogram, the overall trend remains bullish. Valuation metrics are compelling: a trailing PE of 10.3 is well below the industry average of 16.8, and the DCF‑derived fair value of $35.68 implies roughly 18% upside. The company delivers strong profitability with a 41.8% profit margin and a 55% operating margin, and a ROE of 14.6% underscores efficient capital use. Dividend sustainability is high, with a modest 0.7% yield and a payout ratio of just 3.6%, leaving ample room for future increases.
Risk‑adjusted returns appear attractive; beta is low at 0.51, indicating limited market volatility, while 30‑day volatility of 21.7% is moderate for a regional bank. The balance sheet shows a healthy cash position of $182.9M against $132.8M of debt, and the max drawdown of under 10% reflects resilience. Given these fundamentals, CBK presents a value‑oriented investment with upside potential and low dividend risk, suitable for investors seeking stable earnings and modest growth in the financial services sector.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price holding above support and SMA levels
  • Increasing volume supporting the bullish trend
  • MACD bearish histogram suggesting caution

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value indicates ~18% upside
  • PE well below industry average
  • Strong profit margins and low beta

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustainable dividend with low payout ratio
  • Consistent profitability and solid ROE
  • Defensive regional bank exposure with limited volatility

Key Metrics & Analysis

Financial Health

Revenue Growth5.30%
Profit Margin41.77%
P/E Ratio10.3
ROE14.64%
ROA1.65%
P/B Ratio1.3
Op. Cash Flow$38.4M
Industry P/E16.8

Technical Analysis

TrendBullish
RSI54.2
Support$27.25
Resistance$29.75
MA 20$28.68
MA 50$27.61
MA 200$25.85
MACDBearish
VolumeIncreasing
Fear & Greed Index91.8

Valuation

Fair Value$35.68
Target Price$34.00
Upside/Downside18.51%
GradeUndervalued
TypeValue
Dividend Yield0.70%

Risk Assessment

Beta0.51
Volatility21.68%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.